Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 2, 2009, Pages 472-482

  Shanmugasundaram, N ^a   Uma, T S ^a   Lakshmi, T S Ramyaa ^a   Babu, Mary ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Collagen scaffold; Matrix metalloproteinases; Proinflammatory cytokine; Pseudomonas aeruginosa; Silver sulfadiazine

Indexed keywords

COLLAGEN SCAFFOLD; MATRIX METALLOPROTEINASES; PROINFLAMMATORY CYTOKINE; PSEUDOMONAS AERUGINOSA; SILVER SULFADIAZINE;

COLLAGEN; SCAFFOLDS;

SILVER;

COLLAGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; SULFADIAZINE SILVER; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; HEXOSAMINE; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN INFECTION; CELL INFILTRATION; COLONY FORMING UNIT; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DERMIS; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; EPIDERMIS; FEMALE; INOCULATION; NONHUMAN; PERSISTENT INFECTION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RAT; THERAPY EFFECT; THICKNESS; TREATMENT RESPONSE; WOUND DRESSING; WOUND HEALING; ANIMAL; BODY WEIGHT; BURN; DELAYED RELEASE FORMULATION; DENSITOMETRY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PATHOLOGY; TOPICAL DRUG ADMINISTRATION; WESTERN BLOTTING; WISTAR RAT; WOUND INFECTION;

ADMINISTRATION, TOPICAL; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; BURNS; COLLAGEN; CYTOKINES; DELAYED-ACTION PREPARATIONS; DENSITOMETRY; ENZYME ACTIVATION; HEXOSAMINES; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; RATS; RATS, WISTAR; SILVER SULFADIAZINE; WOUND HEALING; WOUND INFECTION;

EID: 65549137017     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31997     Document Type: Article

References (35)

1. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;341:738-746. (Pubitemid 29407375)
2. Stieritz DD, Holder IA. Experimental studies of pathogenesis of infections due to Pseudomonas aeruginosa: Description of a burned mouse model. J Infect Dis 1975;131:688-691.
3. Steinstraesser L, Burkhard O, Fan MH, Jacobsen F, Marcus L, Su G, Daigler A, Steinau HU, Remick D, Wang SC. Burn wounds infected with Pseudomonas aeruginosa triggers wight loss in rats. BMC Surg 2005;5:1-7. (Pubitemid 41426871)
4. Smith M, Enquist IF. A quantitative study of impaired healing resulting from infection. Surg Gyn Obstet 1967;125:965-973.
5. Robson MC. A failure of wound healing caused by an imbalance of bacteria. Surg Clin N Am 1997;77:637-650.
6. Singer AJ, McLain SA. Persistent wound infection delays epidermal maturation and increased scarring in thermal burns. Wound Repair Regen 2002;10:372-377. (Pubitemid 36025336)
7. Freudenberg MA, Ness T, Kumazawa Y, Galanos C. The role of cytokines in endotoxic shock and in endotoxin hypersensitivity. Immun Infekt 1993;21:40-44. (Pubitemid 23154914)
8. Reddy RC, Chen GH, Tekchandani RK, Standiford TJ. Sepsis-induced immunosuppression: From bad to worse. Immunol Res 2001;24:273-287. (Pubitemid 33064386)
9. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68:1-7.
10. Neely AN, Hoover DL, Holder IA, Cross AS. Circulating levels of Tumour Necrosis Factor. Interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns 1996;22:524-530.
11. Grellner W. Time-dependent immunohistochemical detection of proinflammatory cytokines (IL- Beta. IL-6, TNF-Alpha) in human skin wounds. Forensic Sci Int 2002;130:90-96. (Pubitemid 35449641)
12. Armstrong DG, Jude EB. The role of matrix metalloproteinases in wound healing. J Am Podiatr Med Assoc 2002;92:12-18. (Pubitemid 44383824)
13. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997;9:1439-1442.
14. Shapino SD. Matrix metalloproteinases degradation of extracellular matrix: Biological consequences. Cell Biol 1998;10:602-608. (Pubitemid 28477018)
15. Monafo WW, Freedman B. Topical therapy for burns. Surg Clin North Am 1987;67:133-145. (Pubitemid 17024423)
16. Shanmugasundaram N, Sundaraseelan J, Uma S, Selvaraj D, Mary Babu. Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold. J Biomed Mater Res B Appl Biomater 2006;77:378-388. (Pubitemid 43667461)
17. Official monograph of silver sulphadiazine cream. USP 24-NF 19;1999. p 1567.
18. Fujii T, Kuhn K. Isolation and characterization of pepsin-treated type III collagen from calfskin. Hoppe Seylers Z Physiol Chem 1975;11:1793-1801.
19. National Committee for Clinical Lab Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacterial that grow aerobically; approved standard, 5th ed, 2000;20:M7-A5.
20. Grzybowski J, Janiak MK, Oldak E, Lasocki K, Wrembel-Wargocka J, Cheda A, Antos-Bielska M, Pojda Z. New cytokine dressings. II. Stimulation of oxidative burst in leucocytes in vitro and reduction of viable bacteria within an infected wound. Int J Pharm 1999;184:179-187. (Pubitemid 29317651)
21. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-447.
22. Elson LA, Morgan WT. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 1931;27:1824-1828.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85. (Pubitemid 16258399)
24. Madlener M, Parks WC, Werner S. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res 1988;242:201-210. (Pubitemid 28366535)
25. Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P. Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997;137:67-77. (Pubitemid 27167296)
26. Watts AMI, Tyler MPH, Perry ME, Roberts AHN, McGrouther DA. Burn depth and its histological measurement. Burns 2001;27:154-160. (Pubitemid 32156989)
27. Young PK, Grinell F. Metalloproteinases activation cascade after burn injury: A longitudinal analysis of human wound environment. J Invst Dermatol 1994;103:660-664. (Pubitemid 24350132)
28. Raju DR, Jindrak K, Weiner M, Enquist IF. A study of the critical bacterial inoculum to cause a stimulus to wound healing. Surg Gynecol Obstet 1977;144:347-350. (Pubitemid 8198657)
29. Barrow RE, Meyer NA, Jeschke MG. Effect of varying burn sizes and ambient temperature on the hypermetabolic rate in thermally injured rats. J Surg Res 2001;99:253-257. (Pubitemid 32703444)
30. Schaffer CJ, Reinisch L, Polis SL, Stricklin GP, Nanney LB. Comparison of wound healing among excisional, laser-created and standard thermal burns in porcine wounds of equal depth. Wound Repair Regen 1997;5:52-61. (Pubitemid 127686721)
31. Miyajima S, Akaike T, Matsumoto K, Okamoto T, Yoshitake J, Hayashida K, Negi A, Maeda H. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokine in vitro. Microb Pathogol 2001;31:271-281. (Pubitemid 34084419)
32. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing event in a porcine model of contaminated wounds: Effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002;10:141-151. (Pubitemid 34760892)
33. Boosalis MG, McCall JT, Ahrenholz DH, Solem LD, McClain CJ. Serum and urinary silver levels in thermal injury patients. Surgery 1987;101:40-43. (Pubitemid 17218377)
34. Gear AJ, Hellewell TB, Wright HR, Mazzarese PM, Arnold PB, Rodeheaver GT, Edlich RF. A new silver sulfadiazine water soluble gel. Burns 1997;23:387-391. (Pubitemid 27515223)
35. Babu R, Zhang J, Beckman EJ, Virji M, Pasculle WA, Wells A. Antimicrobial activities of silver used as a polymerization catalyst for a wound-healing matrix. Biomaterials 2006;27:4304-4314. (Pubitemid 44275244)